Based on 30 analysts giving stock ratings to Bristol-Myers Squibb Co in the past month.
In the current month, BMY has received 6 Buy Ratings, 18 Hold Ratings, and 1 Sell Ratings. BMY average Analyst price target in the last month is 64.962.
Based on analysts' estimates, BMY EPS is projected to reach 1.495 in FY2026Q4, following reported EPS of 1.058 in FY2026Q3. Track earnings expectations against reported figures to see how profitability is evolving.
The market expectation was USD 1.06, while Bristol-Myers Squibb CoBMY's earnings per share (EPS) for the previous quarter was USD 1.62. EPS for the next quarter is expected at USD 1.50.